Parecoxib ≥97.0% (by HPLC, titration analysis)
Proveedor: TCI
|
Peligro
|
Sinónimos:
N-[[4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl]sulphonyl]propionamide, N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulphonyl)propionamide
P2579-250MG
P2579-50MG
TCIAP2579-250MGEA
317
EUR
TCIAP2579-250MG
TCIAP2579-50MG
Parecoxib ≥97.0% (by HPLC, titration analysis)
Parecoxib
This product is unavailable in the U.S.
Formula:
C₁₉H₁₈N₂O₄S MW: 370,42 g/mol Temperatura de almacenaje: Congelador |
Número MDL:
MFCD08141856 Núm. CAS: 198470-84-7 Índice Merck: 14,07036 |
Resultados test especificaciones
Appearance | White to Almost white powder to crystal |
Purity (HPLC) | min. 97.0 area% |
Purity (Neutralization titration) | min. 97.0 % |
Melting point | 153.0 to 157.0 deg-C |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...